IRIS Accounts Production v24.3.0.553 04244397 director 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary A 0.10000 Ordinary B 0.10000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042443972023-03-31042443972024-03-31042443972023-04-012024-03-31042443972022-03-31042443972022-04-012023-03-31042443972023-03-3104244397ns15:EnglandWales2023-04-012024-03-3104244397ns14:PoundSterling2023-04-012024-03-3104244397ns10:Director12023-04-012024-03-3104244397ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3104244397ns10:SmallEntities2023-04-012024-03-3104244397ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104244397ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104244397ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104244397ns10:FullAccounts2023-04-012024-03-310424439712023-04-012024-03-3104244397ns10:OrdinaryShareClass12023-04-012024-03-3104244397ns10:OrdinaryShareClass22023-04-012024-03-3104244397ns10:CompanySecretary12023-04-012024-03-3104244397ns10:RegisteredOffice2023-04-012024-03-3104244397ns5:CurrentFinancialInstruments2024-03-3104244397ns5:CurrentFinancialInstruments2023-03-3104244397ns5:ShareCapital2024-03-3104244397ns5:ShareCapital2023-03-3104244397ns5:RetainedEarningsAccumulatedLosses2024-03-3104244397ns5:RetainedEarningsAccumulatedLosses2023-03-3104244397ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3104244397ns5:PatentsTrademarksLicencesConcessionsSimilar2023-03-3104244397ns5:PatentsTrademarksLicencesConcessionsSimilar2024-03-3104244397ns5:PatentsTrademarksLicencesConcessionsSimilar2023-03-3104244397ns5:LeaseholdImprovements2023-03-3104244397ns5:FurnitureFittings2023-03-3104244397ns5:MotorVehicles2023-03-3104244397ns5:ComputerEquipment2023-03-3104244397ns5:LeaseholdImprovements2023-04-012024-03-3104244397ns5:FurnitureFittings2023-04-012024-03-3104244397ns5:MotorVehicles2023-04-012024-03-3104244397ns5:ComputerEquipment2023-04-012024-03-3104244397ns5:LeaseholdImprovements2024-03-3104244397ns5:FurnitureFittings2024-03-3104244397ns5:MotorVehicles2024-03-3104244397ns5:ComputerEquipment2024-03-3104244397ns5:LeaseholdImprovements2023-03-3104244397ns5:FurnitureFittings2023-03-3104244397ns5:MotorVehicles2023-03-3104244397ns5:ComputerEquipment2023-03-3104244397ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3104244397ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3104244397ns10:OrdinaryShareClass12024-03-3104244397ns10:OrdinaryShareClass22024-03-31
REGISTERED NUMBER: 04244397 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

MEDICAL ACCESS LIMITED

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MEDICAL ACCESS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTOR: N D Studdart



SECRETARY: N D Studdart



REGISTERED OFFICE: Unit 6 Europa Court
Dee View Boulevard
Chester
Cheshire
CH1 4NP



REGISTERED NUMBER: 04244397 (England and Wales)



ACCOUNTANTS: Gibson Booth Limited
12 Victoria Road
Barnsley
South Yorkshire
S70 2BB



BANKERS: National Westminster Bank Plc
56 Westgate
Wakefield
West Yorkshire
WF1 1XF

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

BALANCE SHEET
31 MARCH 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 95,165 4,457
95,165 4,457

CURRENT ASSETS
Stocks 406,329 333,047
Debtors 6 364,028 461,892
Cash at bank and in hand 572,034 782,102
1,342,391 1,577,041
CREDITORS
Amounts falling due within one year 7 716,933 707,391
NET CURRENT ASSETS 625,458 869,650
TOTAL ASSETS LESS CURRENT
LIABILITIES

720,623

874,107

PROVISIONS FOR LIABILITIES 23,791 847
NET ASSETS 696,832 873,260

CAPITAL AND RESERVES
Called up share capital 9 125 125
Retained earnings 696,707 873,135
SHAREHOLDERS' FUNDS 696,832 873,260

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

BALANCE SHEET - continued
31 MARCH 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 October 2024 and were signed by:





N D Studdart - Director


MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Medical Access Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest pound.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover from the sale of medical consumables is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, usually upon dispatch of the goods, the amount of revenue can be measured reliably, it is probable the the economic benefit associated with the transaction will flow to the entity and the costs incurred in respect of the transaction can be measured reliably.

Intangible assets
Intangible assets are initially recorded at cost. After initial recognition, intangible assets are stated at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website development25% straight line

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life:

Improvements to property20% straight line
Fixtures and fittings20% straight line
Computer equipment25% straight line

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Costs is calculated using the first-in, first-out method and includes all costs associated with bringing the stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Operating lease commitments
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profits on a straight line basis over the period of the lease.

Revenue grants
Grants which are received for compensation for expenses or losses which have already been incurred are recognisable in income when the grant is received or receivable.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Website
development
£   
COST
At 1 April 2023
and 31 March 2024 7,700
AMORTISATION
At 1 April 2023
and 31 March 2024 7,700
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 April 2023 2,448 14,905 - 22,746 40,099
Additions 1,059 - 97,900 - 98,959
At 31 March 2024 3,507 14,905 97,900 22,746 139,058
DEPRECIATION
At 1 April 2023 1,042 12,888 - 21,712 35,642
Charge for year 701 701 6,119 730 8,251
At 31 March 2024 1,743 13,589 6,119 22,442 43,893
NET BOOK VALUE
At 31 March 2024 1,764 1,316 91,781 304 95,165
At 31 March 2023 1,406 2,017 - 1,034 4,457

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 335,518 417,501
Other debtors 13,100 13,900
Prepayments and accrued income 15,410 30,491
364,028 461,892

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors 464,540 516,274
Amounts owed to group undertakings 182 607
Corporation tax 154,767 101,577
Social security and other taxes 5,469 6,093
VAT 86,322 77,156
Other creditors 430 405
Accruals and deferred income 5,223 5,279
716,933 707,391

8. FINANCIAL COMMITMENTS

The total financial commitments which are not included in the balance sheet amount to £27,563 (2023 - £46,463).

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
625 Ordinary A 10p 62 62
625 Ordinary B 10p 63 63
125 125

10. RELATED PARTY TRANSACTIONS

Entities with control, joint control or significant influence
over the entity


2024 2023
£ £
Dividends paid to related party 706,000 332,500
Amounts due to/(from) related party 182 607

MEDICAL ACCESS LIMITED (REGISTERED NUMBER: 04244397)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

11. PARENT UNDERTAKING

The parent undertaking is Nasmal Limited.

The parent company's registered office address is:

Unit 6 Europa Court
Dee View Boulevard
Chester
Cheshire
CH1 4NP